HomeCare December 9, 2024

The English company gained $33 million in its latest Series C funding round, which aims to secure U.S. reimbursement for its wound care products & continuous topical oxygen therapy technologies

CAMBRIDGE, England—Inotec AMD, a medical equipment manufacturer, announced the close of its $33 million Series C financing round. The company said this funding—led by investors Amadeus Capital Partners, Meltwind, Puhua Capital and the Wealth Club—intends to further its mission to heal chronic wounds and improve patients’ lives on a global scale.

The company said the proceeds from this funding round will be used to secure national reimbursement in the U.S. for the company’s advanced wound care product “Natrox O2,” as well as to ensure broader product accessibility for patients across...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Investments, Medical Devices, Trends
Related Articles:
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry
Cala Health Snags $50M for At-Home Tremor Relief Therapy

Share This Article